The National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-has published a new book explaining ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

These are the FDA-approved options to test for prostate, colorectal, and cervical cancer.

Free, comprehensive guidebook shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving lives.

Dr. Paul Dale discusses the importance of cancer screenings, including breast, prostate, skin, and colorectal cancers, and ...

The prostate-specific antigen test measures the level of PSA in the blood. Elevated levels may indicate prostate issues, ...

Learn about prostate cancer risks, warning signs, and the importance of PSA testing for early detection and treatment.

An estimated 1 in 8 men will be diagnosed with prostate cancer in their lifetime, often after 65. And as terrifying as that number is, a diagnosis isn’t always quite what it seems. Today, the vast ...

About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis – the detection of a cancer that would never have been diagnosed during a patient’s ...

AMPLIFY: A phase 3 study of 64Cu-SAR-bisPSMA positron emission tomography in participants with biochemical recurrence of prostate cancer. SOLACE: A phase 1 pharmacokinetic, dosimetry, safety, and dose ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...